VCU’s Department of Neurology is engaged in basic and clinical research to better understand the underlying cause of complex neurological diseases and conditions that translates research discoveries into new treatments. As research, education and practice intersects, VCU and VCU Health are redefining the future of neurological patient care by developing potentially transformative disease modifying therapies. In parallel, researchers are working to redefine how we diagnosis and manage complicated neurological diseases.

Collectively, this work enables neurology researchers to apply the latest in research to treat epilepsy, sleep disorders, stroke, chronic pain and migraine, neuromuscular diseases such as amyotrophic lateral sclerosis (ALS); neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease, and studies of cancers of the brain and nervous system (neuro-oncology).

The Vice-Chair for Research, Nicholas E. Johnson, MD works closely with Chair of the Department to oversee activities pertaining to the research goals of the Department. This includes developing and implementing research initiatives and mechanisms to ensure ongoing support for a growing research infrastructure.

The research interests of faculty within the Department of Neurology span the spectrum from basic laboratory research investigating diseases at a molecular and genetic level, to dedicated clinical outcomes research and finally to translation of knowledge from bench to bedside.

Our departmental research portfolio is diverse, including support from the National Institutes of Health, Department of Defense, patient foundations, and industry sponsors. 

For a list of active clinical trials and research studies, visit the C. Kenneth and Diane Wright Center for Clinical and Translational Research website. To learn more about research and innovation at VCU, explore the Research and Innovation website.

About the Vice Chair for Research

VCUSOM Message from the Dean - About the Chief

About the Vice Chair for Research

Nicholas E. Johnson, MD, MSCI, FAAN is the Director of the Center for Inherited Myology Research (CIMR), Armas Family Endowed Chair in Pediatric Muscular Dystrophy, and vice chair of research in Neurology at Virginia Commonwealth University. He received his undergraduate degree in molecular and cellular biology and psychology at the University of Arizona. He then obtained his medical degree at the University of Arizona. He completed his neurology residency and combined fellowship in neuromuscular medicine and experimental therapeutics at the University of Rochester.

 He leads the GRASP-LGMD consortium, which focuses on developing clinical outcomes and biomarkers in the limb girdle muscular dystrophies and the Myotonic Dystrophy Clinical Research Network which focuses on developing clinical outcomes and biomarkers in the myotonic dystrophies.  Both networks include sites across the United States, Europe, Canada, Japan, and New Zealand with multiple natural history protocols.  His laboratory is focused on identifying the pathogenesis and progression of myotonic dystrophy, and biomarkers in limb girdle muscular dystrophy. Johnson conducts genetic therapeutic trials using both viral and non-viral approaches in many inherited nerve and muscle disorders, including limb girdle muscular dystrophy, myotonic dystrophy, and facioscapulohumeral muscular dystrophy.